Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder

Psychiatry Research

Volumn 210, Issue 1, 2013, Pages 346-350

  Hamazaki, Kei ^a   Hamazaki, Tomohito ^b   Inadera, Hidekuni ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Bipolar disorder; Case control study; Entorhinal cortex; Major depressive disorder; Polyunsaturated fatty acids; Postmortem brain; Schizophrenia

Indexed keywords

ARACHIDIC ACID; BEHENIC ACID; DOCOSAPENTAENOIC ACID; ICOSATETRAENOIC ACID; LIGNOCERIC ACID; LINOLENIC ACID; MYRISTIC ACID; OLEIC ACID; PALMITOLEIC ACID; STEARIC ACID; VACCENIC ACID;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN LEVEL; CONTROLLED STUDY; DSM-IV; ENTORHINAL CORTEX; FEMALE; GAS CHROMATOGRAPHY; HEMISPHERE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; LIPID COMPOSITION; MAJOR DEPRESSION; MALE; ORBITAL CORTEX; PH MEASUREMENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE; SUICIDE;

AA; ARACHIDONIC ACID; BIPOLAR DISORDER; CASE-CONTROL STUDY; DHA; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; DPA; ENTORHINAL CORTEX; MAJOR DEPRESSIVE DISORDER; MDD; POLYUNSATURATED FATTY ACIDS; POSTMORTEM BRAIN; PUFAS; SCHIZOPHRENIA; SMRI; THE STANLEY MEDICAL RESEARCH INSTITUTE;

ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; ENTORHINAL CORTEX; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; SCHIZOPHRENIA;

EID: 84885860989     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.05.006     Document Type: Article

References (40)

1. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:10858-10863.
2. Arnold S.E. Cellular and molecular neuropathology of the parahippocampal region in schizophrenia. Annals of the New York Academy of Sciences 2000, 911:275-292.
3. Arvindakshan M., Sitasawad S., Debsikdar V., Ghate M., Evans D., Horrobin D.F., Bennett C., Ranjekar P.K., Mahadik S.P. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological Psychiatry 2003, 53:56-64.
4. Baiano M., Perlini C., Rambaldelli G., Cerini R., Dusi N., Bellani M., Spezzapria G., Versace A., Balestrieri M., Mucelli R.P., Tansella M., Brambilla P. Decreased entorhinal cortex volumes in schizophrenia. Schizophrenia Research 2008, 102:171-180.
5. Bazán N.G. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochimica et Biophysica Acta 1970, 218:1-10.
6. Bell-McGinty S., Butters M.A., Meltzer C.C., Greer P.J., Reynolds C.F., Becker J.T. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. American Journal of Psychiatry 2002, 159:1424-1427.
7. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 1959, 37:911-917.
8. Buydens-Branchey L., Branchey M., Hibbeln J.R. Low plasma levels of docosahexaenoic acid are associated with an increased relapse vulnerability in substance abusers. American Journal on Addictions/American Academy of Psychiatrists in Alcoholism and Addictions 2009, 18:73-80.
9. Calderon F., Kim H.Y. Docosahexaenoic acid promotes neurite growth in hippocampal neurons. Journal of Neurochemistry 2004, 90:979-988.
10. Cao D., Kevala K., Kim J., Moon H.S., Jun S.B., Lovinger D., Kim H.Y. Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. Journal of Neurochemistry 2009, 111:510-521.
11. Chiu C.C., Huang S.Y., Su K.P., Lu M.L., Huang M.C., Chen C.C., Shen W.W. Polyunsaturated fatty acid deficit in patients with bipolar mania. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2003, 13:99-103.
12. Conklin S.M., Gianaros P.J., Brown S.M., Yao J.K., Hariri A.R., Manuck S.B., Muldoon M.F. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neuroscience Letters 2007, 421:209-212.
13. Delaloye C., de Bilbao F., Moy G., Baudois S., Weber K., Campos L., Canuto A., Giardini U., von Gunten A., Stancu R.I., Scheltens P., Lazeyras F., Millet P., Giannakopoulos P., Gold G. Neuroanatomical and neuropsychological features of euthymic patients with bipolar disorder. American Journal of Geriatric Psychiatry 2009, 17:1012-1021.
14. Evans D.R., Parikh V.V., Khan M.M., Coussons C., Buckley P.F., Mahadik S.P. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2003, 69:393-399.
15. Furtado C.P., Maller J.J., Fitzgerald P.B. A magnetic resonance imaging study of the entorhinal cortex in treatment-resistant depression. Psychiatry Research 2008, 163:133-142.
16. Gerritsen L., Comijs H.C., van der Graaf Y., Knoops A.J., Penninx B.W., Geerlings M.I. Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes--the SMART Medea study. Biological Psychiatry 2011, 70:373-380.
17. Hamazaki K., Choi K.H., Kim H.Y. Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species. Journal of Psychiatric Research 2010, 44:688-693.
18. Hamazaki K., Hamazaki T., Inadera H. Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder. Journal of Psychiatric Research 2012, 46:1024-1028.
19. Huan M., Hamazaki K., Sun Y., Itomura M., Liu H., Kang W., Watanabe S., Terasawa K., Hamazaki T. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biological Psychiatry 2004, 56:490-496.
20. Kalus P., Slotboom J., Gallinat J., Federspiel A., Gralla J., Remonda L., Strik W.K., Schroth G., Kiefer C. New evidence for involvement of the entorhinal region in schizophrenia: a combined MRI volumetric and DTI study. NeuroImage 2005, 24:1122-1129.
21. Kawakita E., Hashimoto M., Shido O. Docosahexaenoic acid promotes neurogenesis in vitro and in vivo. Neuroscience 2006, 139:991-997.
22. Khan M.M., Evans D.R., Gunna V., Scheffer R.E., Parikh V.V., Mahadik S.P. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Research 2002, 58:1-10.
23. Krimer L.S., Hyde T.M., Herman M.M., Saunders R.C. The entorhinal cortex: an examination of cyto- and myeloarchitectonic organization in humans. Cereb Cortex 1997, 7:722-731.
24. Lalovic A., Klempan T., Sequeira A., Luheshi G., Turecki G. Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. Journal of Affective Disorders 2010, 120:24-31.
25. Lalovic A., Levy E., Canetti L., Sequeira A., Montoudis A., Turecki G. Fatty acid composition in postmortem brains of people who completed suicide. Journal of Psychiatry and Neuroscience 2007, 32:363-370.
26. Lewis M.D., Hibbeln J.R., Johnson J.E., Lin Y.H., Hyun D.Y., Loewke J.D. Suicide deaths of active-duty US military and omega-3 fatty-acid status: a case-control comparison. Journal of Clinical Psychiatry 2011, 72:1585-1590.
27. Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry 2010, 68:140-147.
28. McNamara R.K., Hahn C.G., Jandacek R., Rider T., Tso P., Stanford K.E., Richtand N.M. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biological Psychiatry 2007, 62:17-24.
29. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. Journal of Affective Disorders 2010, 126:303-311.
30. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Roberts R.C., Conley R.R., Pandey G.N. Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2009, 80:19-26.
31. McNamara R.K., Jandacek R., Rider T., Tso P., Hahn C.G., Richtand N.M., Stanford K.E. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophrenia Research 2007, 91:37-50.
32. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K.E., Hahn C.G., Richtand N.M. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Research 2008, 160:285-299.
33. McNamara R.K., Liu Y. Reduced expression of fatty acid biosynthesis genes in the prefrontal cortex of patients with major depressive disorder. Journal of Affective Disorders 2011, 129:359-363.
34. Pawlosky R.J., Salem N. Alcohol consumption in rhesus monkeys depletes tissues of polyunsaturated fatty acids and alters essential fatty acid metabolism. Alcoholism, Clinical and Experimental Research 1999, 23:311-317.
35. Pearlson G.D., Barta P.E., Powers R.E., Menon R.R., Richards S.S., Aylward E.H., Federman E.B., Chase G.A., Petty R.G., Tien A.Y. Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biological Psychiatry 1997, 41:1-14.
36. Poudel-Tandukar K., Nanri A., Iwasaki M., Mizoue T., Matsushita Y., Takahashi Y., Noda M., Inoue M., Tsugane S. Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women-the Japan Public Health Center-based (JPHC) prospective study. Journal of Affective Disorders 2011, 129:282-288.
37. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research 2003, 121:109-122.
38. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 2000, 44:151-155.
39. Tu W.C., Muhlhausler B.S., Yelland L.N., Gibson R.A. Correlations between blood and tissue omega-3 LCPUFA status following dietary ALA intervention in rats. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2013, 88:53-60.
40. Turetsky B.I., Moberg P.J., Roalf D.R., Arnold S.E., Gur R.E. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Archives of General Psychiatry 2003, 60:1193-1200.